Abstract 18P
Background
High neutrophil to lymphocyte ratio may reflect the key role of systemic inflammation in enhancing angiogenesis, tumor growth and development of metastasis The role of lymphocytes cells in cancer control is exemplified by the strong association between high densities of tumor-infiltrating lymphocytes and better responses to both, cytotoxic treatments and outcome in patients with breast cancer.
Methods
A total number of files reviewed is 1167 files and a total of 102 breast cancer patients included in this study with histologically proven early stage (T1–2, N0–1, non-metastatic) breast cancer treated in Babylon Oncology Center from January 2009 to September 2014 were considered for this retrospective study. The following data were collected from patient file: age, date of diagnosis, date of recurrence and/or metastasis, follow up period, histological tumor type, tumor size, tumor-node-metastasis stage, expression of estrogen and/or progesterone receptor, HER-2-neu status, metastasis site and with inclusion criteria of Tumor stage up to stage IIA (T1-T2, N0/ T1, N1), follow up for at least 36 months and pre-treatment CBC with differential count.
Results
With mean age of 50.4 ± 11.7 years and minimum follow up 40 months, the overall median DFS was 62 months with 5 – years DFS of 52.5%, stage N0 show significant better DFS compared to stage N1 (P value 0.004), also patients with positive hormonal status show significant better DFS compared to negative hormonal status (P value 0.029), NLR has significant outcome on DFS when increased the ratio leading to declining in DFS (P value 0.006), NLR fair specificity (76.9%) with lower sensitivity (62.2%), with optimal cut point of > 2.194 to predict DFS with better DFS about 16 months (P value 0.0004), and Hazard Ration is 2.5 (P value 0.007), in univariate analysis the significant Hazard Ratio are NLR, N staging and Hormonal status while in multivariate analysis shows only NLR Hazard Ratio with (0.012 P value). In our study PLR neither sensitive nor specific with non-significant P value so it will not be consider as a prognostic index.
Conclusions
Elevated NLR is strongly associated with poor disease free survival of breast cancer patients.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Iraqi Board for Medical Specialities.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
249P - Accuracy of endometrial biopsy by Pipelle: A systematic review and meta-analysis
Presenter: Jinhai Gou
Session: Poster display session
Resources:
Abstract
250P - Non-endometrioid endometrial cancer: Analysis of different adjuvant treatment modalities
Presenter: Gonçalo Nogueira da Costa
Session: Poster display session
Resources:
Abstract
251P - A prognostic index model for predicting long-term recurrence of uterine leiomyoma after initial myomectomy in women aged 18-44 years
Presenter: Xiu Ming
Session: Poster display session
Resources:
Abstract
252P - Uterine sarcomas in Qatar: Clinico-pathological characteristics and treatment outcome
Presenter: Ashraf Fadlelseid
Session: Poster display session
Resources:
Abstract
253P - Anti-PD-1-induced reinvigoration of tumour-infiltrating CD8+ T cells in epithelial ovarian cancer patients is correlated with T cell factor-1
Presenter: Junsik Park
Session: Poster display session
Resources:
Abstract
254P - Cyclin E1 is a shared biomarker of subsets of high grade serous ovarian cancer (HGSOC) and basal like breast cancer (BLBC)
Presenter: Diar Aziz
Session: Poster display session
Resources:
Abstract
255P - MEX3A is a prognostic biomarker and correlates with RNA splicing and cell proliferation in endometrial cancer by analysis of RNA-seq data
Presenter: Huining Jing
Session: Poster display session
Resources:
Abstract
256P - Lnc-AL445665.1-4 may be involved in the development of multiple uterine leiomyoma through interacting with miR-146b-5p
Presenter: E Yang
Session: Poster display session
Resources:
Abstract
257P - Treatment results of low risk gestational trophoblastic neoplasia (GTN) from a tertiary hospital, Chennai, India
Presenter: Rakesh M. P
Session: Poster display session
Resources:
Abstract
258P - Assessment of sexual health in patients treated for ovarian cancer
Presenter: Renu Madan
Session: Poster display session
Resources:
Abstract